Company news
Oruka Therapeutics, Inc. news in 2020
Oruka Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
December 14, 2020
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
December 8, 2020
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation
November 22, 2020
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
November 1, 2020
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
October 6, 2020
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality
October 4, 2020
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19
September 20, 2020
ARCA Biopharma Announces Completion of FDA Pre-IND Consultation Under Coronavirus Treatment Acceleration Program for AB201 as a Potential Treatment for Severe COVID-19
August 11, 2020
Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update
August 4, 2020
SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators
July 6, 2020
ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering
June 2, 2020
ARCA Biopharma Announces $9.4 Million Registered Direct Offering
May 31, 2020
ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy
May 27, 2020
Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific Sessions
May 6, 2020
ARCA Biopharma Announces First Quarter 2020 Financial Results And Provides Corporate Update
May 5, 2020
ARCA biopharma Announces Fiscal Year 2019 Financial Results and Provides Corporate Update
February 17, 2020